Author:
Liu Yifei,Yang Min,Garg Vishvas,Wu Eric Q.,Wang Jessie,Skup Martha
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference71 articles.
1. US Pharmacist. The use of biologics in cancer therapy.
https://www.uspharmacist.com/article/the-use-of-biologics-in-cancer-therapy
. 2010. Accessed Dec 7 2018.
2. Morrow T, Felcone LH. Defining the difference: what makes biologics unique. Biotechnol Healthc. 2004;1(4):24–9.
3. Declerck P, Danesi R, Petersel D, Jacobs I. The language of biosimilars: clarification, definitions, and regulatory aspects. Drugs. 2017;77(6):671–7.
4. Bridges SL Jr, White DW, Worthing AB, Gravallese EM, O’Dell JR, Nola K, et al. The science behind biosimilars: entering a new era of biologic therapy. Arthritis Rheumatol. 2018;70(3):334–44.
5. Generics and Biosimilars Initiative (GaBI). Biosimilars approved in Europe.
http://www.gabionline.net/Biosimilars/General/Biosimilars-approved-in-Europe
. 2017. Accessed Dec 7 2018.
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献